We follow our purpose to create high-potent pharmaceutical products enabling people to care for their health and improve the quality of life of patients.
All phases—from pharmaceutical development to launching
into production have been established in accordance with current Russian and International Quality standards.
The R&D Center has its own licensed production area for solid dosage forms manufacturing for clinical studies and small-scale commercial batches.
30pharmaceutical product names for treatment of patients with socially significant diseases are in the development stage.
ОТ1
ОК1
NSO1
ОТ4
OT5
OK3
At all phases of generic drug product—from development to launching into production, from API manufacturing to finished dosage form—POLYSAN applies the same responsible and stringent approach as it does to the original drug products.
Generic pharmaceutical products
192102, Russia, Saint Petersburg,
Salova St., 72, Bldg. 2, Lit. A.
192102, Russia, Saint Petersburg,
Salova St., 72, Bldg. 2, Lit. A.
Pharmacovigilance group
of the Medical Department.
